litlas
Log inCreate account

Morag Park

Active 1984–2025

118
Papers
18,288
Citations
76
h-index
114
i10-index

Citations

Citations per year for Morag Park1984: 1 citations1985: 10 citations1986: 19 citations1987: 27 citations1988: 7 citations1989: 14 citations1990: 11 citations1991: 31 citations1992: 20 citations1993: 25 citations1994: 23 citations1995: 21 citations1996: 38 citations1997: 57 citations1998: 74 citations1999: 88 citations2000: 134 citations2001: 117 citations2002: 112 citations2003: 140 citations2004: 123 citations2005: 100 citations2006: 96 citations2007: 113 citations2008: 113 citations2009: 165 citations2010: 179 citations2011: 181 citations2012: 225 citations2013: 199 citations2014: 179 citations2015: 174 citations2016: 141 citations2017: 180 citations2018: 101 citations2019: 440 citations2020: 553 citations2021: 645 citations2022: 555 citations2023: 510 citations2024: 805 citations2025: 494 citations2026: 13 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,515 citing papers, 27.5% of this breakdownChina: 1,408 citing papers, 15.4% of this breakdownCanada: 560 citing papers, 6.1% of this breakdownUnited Kingdom: 501 citing papers, 5.5% of this breakdownItaly: 444 citing papers, 4.8% of this breakdownGermany: 420 citing papers, 4.6% of this breakdownFrance: 363 citing papers, 4% of this breakdownJapan: 282 citing papers, 3.1% of this breakdownAustralia: 194 citing papers, 2.1% of this breakdownSpain: 172 citing papers, 1.9% of this breakdownBelgium: 156 citing papers, 1.7% of this breakdownSwitzerland: 150 citing papers, 1.6% of this breakdown
0%27.5%Other 21.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47%
  • Medicine41.4%
  • Immunology and Microbiology6.5%
  • Neuroscience1.7%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.4%
  • Other1.6%

Topics

  • Cancer Cells and Metastasis4.5%
  • Cancer, Hypoxia, and Metabolism3.1%
  • Liver physiology and pathology2.9%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Immune cells in cancer2.4%
  • Epigenetics and DNA Methylation2.3%
  • Other82.3%

Coauthors

All papers

Open in search
  1. Single-cell spatial immune landscapes of primary and metastatic brain tumours

    Authors: Elham Karimi, Miranda W. Yu, Sarah M. Maritan, Lucas J. M. Perus, Morteza Rezanejad, Mark Sorin, Matthew Dankner, Parvaneh Fallah, Samuel Doré, Dongmei Zuo, Benoit Fiset, Daan J. Kloosterman, LeeAnn Ramsay, Yuhong Wei, Stéphanie Lam, Roa Alsajjan, Ian R. Watson, Gloria Roldan Urgoiti, Morag Park, Dieta Brandsma, Donna L. Senger, Jennifer A. Chan, Leila Akkari, Kevin Petrecca, Marie‐Christine Guiot, Peter M. Siegel, Daniela F. Quail, Logan A. Walsh - Nature 2023 cited by 392

  2. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis

    Authors: Matteo Rossi, Patricia Altea‐Manzano, Margherita Demicco, Ginevra Doglioni, Laura Bornes, Marina Fukano, Anke Vandekeere, Alejandro M. Cuadros, Juan Fernández-García, Carla Riera‐Domingo, Cristina Jauset, Mélanie Planque, H. Furkan Alkan, David Nittner, Dongmei Zuo, Lindsay A. Broadfield, Sweta Parik, Antonino Alejandro Pane, Francesca Rizzollo, Gianmarco Rinaldi, Tao Zhang, Shao Thing Teoh, Arin B. Aurora, Panagiotis Karras, Ines Vermeire, Dorien Broekaert, Joke Van Elsen, Maximilian M. L. Knott, Martin F. Orth, Sofie Demeyer, Guy Eelen, Lacey E. Dobrolecki, Ayse Bassez, Thomas Van Brussel, Karl Sotlar, Michael T. Lewis, Harald Bartsch, Manfred Wuhrer, Peter A. van Veelen, Peter Carmeliet, Jan Cools, Sean J. Morrison, Jean‐Christophe Marine, Diether Lambrechts, Massimiliano Mazzone, Gregory J. Hannon, Sophia Y. Lunt, Thomas G. P. Grünewald, Morag Park, Jacco van Rheenen, Sarah‐Maria Fendt - Nature 2022 cited by 210

  3. Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers

    Authors: Tina Gruosso, Mathieu Gigoux, Venkata Manem, Nicholas Bertos, Dongmei Zuo, Irina Perlitch, Sadiq M.I. Saleh, Hong Zhao, Margarita Souleimanova, Radia Marie Johnson, Anne Monette, Valentina Muñoz Ramos, Michael Hallett, John Stagg, Réjean Lapointe, Atilla Ömeroğlu, Sarkis Meterissian, Laurence Buisseret, Gert Van den Eyden, Roberto Salgado, Marie-Christine Guiot, Benjamin Haibe‐Kains, Morag Park - Journal of Clinical Investigation 2019 cited by 427

  4. Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression

    Authors: Ori Maller, Allison P. Drain, Alexander Barrett, Signe Borgquist, Brian Ruffell, Igor Zakharevich, Thanh Pham, Tina Gruosso, Hellen Kuasne, Johnathon N. Lakins, Irene Acerbi, J. Matthew Barnes, Travis Nemkov, Aastha Chauhan, Jessica Gruenberg, Aqsa Nasir, Olöf Bjarnadottir, Zena Werb, Peter Kabos, Yunn-Yi Chen, E. Shelley Hwang, Morag Park, Lisa M. Coussens, Andrew C. Nelson, Kirk C. Hansen, Valerie M. Weaver - Nature Materials 2020 cited by 307

  5. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer

    Authors: Qin Wu, Wail Ba-Alawi, Geneviève Deblois, Jennifer Cruickshank, Shili Duan, Evelyne Lima‐Fernandes, Jillian Haight, Seyed Ali Madani Tonekaboni, Anne-Marie Fortier, Hellen Kuasne, Trevor D. McKee, Hassan Mahmoud, Michelle Kushida, Sarina Cameron, Nergiz Doğan, Wenjun Chen, Yan Nie, Lan-Xin Zhang, Ravi N. Vellanki, Stanley Zhou, Panagiotis Prinos, Bradly G. Wouters, Peter B. Dirks, Susan J. Done, Morag Park, David W. Cescon, Benjamin Haibe‐Kains, Mathieu Lupien, C.H. Arrowsmith - Nature Communications 2020 cited by 299

  6. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer

    Authors: Tarek Taifour, Sherif Samer Attalla, Dongmei Zuo, Yu Gu, Virginie Sanguin‐Gendreau, Hailey Proud, Emilie Solymoss, Tung Bui, Hellen Kuasne, Vasilios Papavasiliou, Chun Geun Lee, Suchitra Kamle, Peter M. Siegel, Jack A. Elias, Morag Park, William J. Muller - Immunity 2023 cited by 183

  7. Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix

    Authors: Emily Kay, Karla Paterson, Carla Riera‐Domingo, David Sumpton, J. Henry M. Däbritz, Saverio Tardito, Claudia Boldrini, Juan R. Hernández‐Fernaud, Dimitris Athineos, Sandeep Dhayade, Stepanova Ev, Enio Gjerga, Lisa J. Neilson, Sérgio Lilla, Ann Hedley, Grigorios Koulouras, Grace H. McGregor, Craig Jamieson, Radia Marie Johnson, Morag Park, Kristina Kirschner, Crispin Miller, Jurre J. Kamphorst, Fabricio Loayza‐Puch, Julio Sáez-Rodríguez, Massimiliano Mazzone, Karen Blyth, Michele Zagnoni, Sara Zanivan - Nature Metabolism 2022 cited by 154

  8. Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach

    Authors: Yacine Barèche, Laurence Buisseret, Tina Gruosso, Edwina Girard, David Venet, Floriane Dupont, Christine Desmedt, Denis Larsimont, Morag Park, Françoise Rothé, John Stagg, Christos Sotiriou - JNCI Journal of the National Cancer Institute 2019 cited by 204

  9. SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria

    Authors: Yibo Xue, Jordan L. Morris, Kangning Yang, Zheng Qing Fu, Xianbing Zhu, Fraser Johnson, Brian Meehan, Leora Witkowski, Amber Yasmeen, Tünde Golenár, Mackenzie Coatham, Geneviève Morin, Anie Monast, Virginie Pilon, Pierre Fiset, Sungmi Jung, Anne V. Gonzalez, Sophie Camilleri‐Broët, Lili Fu, Lynne‐Marie Postovit, Jonathan Spicer, Walter H. Gotlieb, Marie‐Christine Guiot, Janusz Rak, Morag Park, William W. Lockwood, William D. Foulkes, Julien Prudent, Sidong Huang - Nature Communications 2021 cited by 67

  10. Stromal gene expression predicts clinical outcome in breast cancer

    Authors: Greg Finak, Nicholas Bertos, François Pépin, Svetlana Sadekova, Margarita Souleimanova, Hong Zhao, Haiying Chen, Gülbeyaz Ömeroğlu, Sarkis Meterissian, Atilla Ömeroğlu, Michael Hallett, Morag Park - Nature Medicine 2008 cited by 1,731

  11. VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex

    Authors: Kan Lu, Jeffrey P. Chang, Christine A. Parachoniak, Melissa M. Pandika, Manish K. Aghi, David Meyronet, Nadezda Isachenko, Shaun D. Fouse, Joanna J. Phillips, David A. Cheresh, Morag Park, Gabriele Bergers - Cancer Cell 2012 cited by 555

  12. CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers

    Authors: Tim Kong, Ryuhjin Ahn, Kangning Yang, Xianbing Zhu, Zheng Fu, Geneviève Morin, Rachel Bramley, Nikki C. Cliffe, Yibo Xue, Hellen Kuasne, Qinghao Li, Sungmi Jung, Anne V. Gonzalez, Sophie Camilleri‐Broët, Marie‐Christine Guiot, Morag Park, Josie Ursini‐Siegel, Sidong Huang - Cancer Research 2019 cited by 162

  13. Epigenetic Switch–Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer

    Authors: Geneviève Deblois, Seyed Ali Madani Tonekaboni, Giacomo Grillo, Constanza Martínez, Yunchi Ingrid Kao, Felicia Tai, Ilias Ettayebi, Anne-Marie Fortier, Paul Savage, Alexandra N. Fedor, Xiaojing Liu, Paul Guilhamon, Evelyne Lima‐Fernandes, Alex Murison, Hellen Kuasne, Wail Ba-Alawi, David W. Cescon, C.H. Arrowsmith, Daniel D. De Carvalho, Benjamin Haibe‐Kains, Jason W. Locasale, Morag Park, Mathieu Lupien - Cancer Discovery 2020 cited by 148

  14. ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties

    Authors: April A. N. Rose, Matthew G. Annis, Zhifeng Dong, François Pépin, Michael Hallett, Morag Park, Peter M. Siegel - PLoS ONE 2010 cited by 224

  15. Molecular cloning of a new transforming gene from a chemically transformed human cell line

    Authors: Colin S. Cooper, Morag Park, Donald G. Blair, Michael A. Tainsky, Kay Huebner, Carlo M. Croce, George F. Vande Woude - Nature 1984 cited by 993

  16. Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

    Authors: Yi Du, Hirohito Yamaguchi, Yongkun Wei, Jennifer L. Hsu, Hung-Ling Wang, Yi‐Hsin Elsa Hsu, Wan-Chi Lin, Wen-Hsuan Yu, Paul G. Leonard, Gilbert R. Lee, Mei‐Kuang Chen, Katsuya Nakai, Ming‐Chuan Hsu, Chun‐Te Chen, Ye Sun, Yun Wu, Wei-Chao Chang, Wen-Chien Huang, Chien‐Liang Liu, Yuan-Ching Chang, Chung‐Hsuan Chen, Morag Park, Philip Jones, Gabriel N. Hortobágyi, Mien‐Chie Hung - Nature Medicine 2016 cited by 245

  17. Estrogen-related receptors are targetable ROS sensors

    Authors: Mathieu Vernier, Catherine R. Dufour, Shawn McGuirk, Charlotte Scholtes, Xiaojing Li, G Bourmeau, Hellen Kuasne, Morag Park, Julie St‐Pierre, Étienne Audet‐Walsh, Vincent Giguère - Genes & Development 2020 cited by 109

  18. Dispersible hydrogel force sensors reveal patterns of solid mechanical stress in multicellular spheroid cultures

    Authors: Wontae Lee, Nikita Kalashnikov, Stephanie Mok, Ruba Halaoui, Elena Kuzmin, Andrew J. Putnam, Shuichi Takayama, Morag Park, Luke McCaffrey, Ruogang Zhao, Richard L. Leask, Christopher Moraes - Nature Communications 2019 cited by 146

  19. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

    Authors: Marie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, Ariane Pelletier, Paul Savage, Marie‐Pier Thibault, Radia Marie Johnson, Peter Carmeliet, Mark Basik, Louis Gaboury, William J. Muller, Morag Park, Philippe P. Roux, Jean‐Philippe Gratton, Jean‐François Côté - Cell Reports 2018 cited by 144

  20. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary

    Authors: Yibo Xue, Brian Meehan, Elizabeth A. Macdonald, Sriram Venneti, Xue Qing David Wang, Leora Witkowski, Petar Jelinic, Tim Kong, Daniel Martínez, Geneviève Morin, Michelle Firlit, Atefeh Abedini, Radia Marie Johnson, Regina Cencic, Jahnavi Patibandla, Hongbo Chen, Andreas I. Papadakis, Aurélie Auguste, Iris de Rink, Ron Kerkhoven, Nicholas Bertos, Walter H. Gotlieb, Blaise Clarke, Alexandra Léary, Michael Witcher, Marie‐Christine Guiot, Jerry Pelletier, Josée Dostie, Morag Park, Alexander R. Judkins, Ralf Hass, Douglas A. Levine, Janusz Rak, Barbara C. Vanderhyden, William D. Foulkes, Sidong Huang - Nature Communications 2019 cited by 115

  21. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels

    Authors: Marie-Anne Goyette, Islam E. Elkholi, Chloé Apcher, Hellen Kuasne, Carla V. Rothlin, William J. Muller, Darren E. Richard, Morag Park, Jean‐Philippe Gratton, Jean‐François Côté - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 61

  22. A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion

    Authors: Antoine Khalil, Daan Smits, Peter D. Haughton, Thijs Koorman, Karin A. Jansen, Mathijs Verhagen, Mirjam van der Net, Kitty van Zwieten, Lotte Enserink, Lisa T. Jansen, A. El-Gammal, Daan Visser, Milena Pasolli, Max Tak, Denise Westland, P. J. van Diest, Cathy B. Moelans, M. Guy Roukens, Sandra Tavares, Anne-Marie Fortier, Morag Park, Riccardo Fodde, Martijn Gloerich, Fried Zwartkruis, Patrick W.B. Derksen, Johan de Rooij - Nature Communications 2024 cited by 44

  23. Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer

    Authors: Xianbing Zhu, Zheng Fu, Kendall Dutchak, Azadeh Arabzadeh, Simon Milette, Jutta Steinberger, Geneviève Morin, Anie Monast, Virginie Pilon, Tim Kong, Bianca N. Adams, Érika Prando Munhoz, Hannah J.B. Hosein, Tianxu Fang, Jing Su, Yibo Xue, Roni Rayes, Veena Sangwan, Logan A. Walsh, Guojun Chen, Daniela F. Quail, Jonathan Spicer, Morag Park, David Dankort, Sidong Huang - Cancer Research 2024 cited by 40

  24. Infiltration of CD8 + T cells into tumor cell clusters in triple-negative breast cancer

    Authors: Xuefei Li, Tina Gruosso, Dongmei Zuo, Atilla Ömeroğlu, Sarkis Meterissian, Marie‐Christine Guiot, Adam Salazar, Morag Park, Herbert Levine - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 141